RxSight

Update in progress

RXST (NasdaqGM)

Company RatingNeutral
SectorHealthcare
IndustryMedical Devices

RxSight, Inc. is a commercial-stage medical technology company that develops, manufactures, and sells light-adjustable intraocular lenses (LALs) for cataract surgery in the United States. Its RxSight system includes the Light Adjustable Lens, made of photosensitive material that adjusts shape with UV exposure, and an office-based light delivery device to program the correction. Formerly Calhoun Vision, the company was renamed in 2017 and is based in Aliso Viejo, California.

Company score

Sentiment: 0.33; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.00; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.32; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.09; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.11; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.22; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive